Posts From King World News

MEI Pharma shares swoon as cancer drug fails study

MEI Pharma lost more than two-thirds of its market value on Monday after the company’s cancer drug failed to meet the main goal in a mid-stage study. The drug, pracinostat, was being tested in combination with chemotherapy drug azacitidine to treat patients with myelodysplastic syndrome (MDS) – a blood cancer where immature blood cells in the bone marrow fail to become healthy cells. The trial failure raised questions about the

Appreciation for Brian Wansink, Run Amok

I love Brian Wansink and so was delighted to see his work celebrated quite prominently this past week. That is, I was delighted up to a point.When I say I love Brian, I mean it quite genuinely, and both personally and professionally. Personally, we are friends. Brian could well have inspired the lyrics of “for he’s a jolly good fellow.” A good…

Uncommon form of heart attack likely runs in family: study

By Sharon Begley NEW YORK (Reuters) – Although oncologists increasingly distinguish breast, lung, and other cancers by their molecular drivers, cardiologists have lagged behind in efforts to do something similar for heart disease. A study published on Monday could help remedy that: Researchers have found evidence of a genetic basis for an enigmatic kind of heart attack that preferentially strikes young women. Just as breast cancers driven by one mutation

Top 5 Reasons to Celebrate Obamacare's 5th Anniversary

Doctors in white coats marched in the rain from Freedom Plaza near the White House to Capitol Hill in Washington, D.C. on March 22, 2010 to show support for health reform and to ask the Senate to do likewise. I was one of those doctors, drenched but undeterred. We represented thousands of health care providers in organizations like the National…